Your browser doesn't support javascript.
Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray.
Hosseinian, Sina; Powers, Kathleen; Vasudev, Milind; Palma, Anton M; de Assis, Rafael; Jain, Aarti; Horvath, Peter; Birring, Paramveer S; Andary, Rana; Au, Connie; Chin, Brandon; Khalil, Ghali; Ventura, Jenny; Luu, Madeleine K; Figueroa, Cesar; Obiero, Joshua M; Silzel, Emily; Nakajima, Rie; Gombrich, William Thomas; Jasinskas, Algis; Zaldivar, Frank; Schubl, Sebastian; Felgner, Philip L; Khan, Saahir.
  • Hosseinian S; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Powers K; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Vasudev M; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Palma AM; Institute for Clinical and Translational Science, University of California Irvine, Irvine, CA, United States.
  • de Assis R; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
  • Jain A; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
  • Horvath P; Institute for Clinical and Translational Science, University of California Irvine, Irvine, CA, United States.
  • Birring PS; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Andary R; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Au C; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Chin B; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Khalil G; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Ventura J; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Luu MK; School of Biological Sciences, University of California Irvine, Irvine, CA, United States.
  • Figueroa C; Department of Surgery, School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Obiero JM; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
  • Silzel E; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
  • Nakajima R; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
  • Gombrich WT; School of Biological Sciences, University of California Irvine, Irvine, CA, United States.
  • Jasinskas A; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
  • Zaldivar F; Institute for Clinical and Translational Science, University of California Irvine, Irvine, CA, United States.
  • Schubl S; Department of Pediatrics, University of California Irvine, Irvine, CA, United States.
  • Felgner PL; School of Medicine, University of California Irvine, Irvine, CA, United States.
  • Khan S; Department of Surgery, School of Medicine, University of California Irvine, Irvine, CA, United States.
Front Immunol ; 13: 817345, 2022.
Article in English | MEDLINE | ID: covidwho-1875411
ABSTRACT
Recent studies provide conflicting evidence on the persistence of SARS-CoV-2 immunity induced by mRNA vaccines. Here, we aim to quantify the persistence of humoral immunity following vaccination using a coronavirus antigen microarray that includes 10 SARS-CoV-2 antigens. In a prospective longitudinal cohort of 240 healthcare workers, composite SARS-CoV-2 IgG antibody levels did not wane significantly over a 6-month study period. In the subset of the study population previously exposed to SARS-CoV-2 based on seropositivity for nucleocapsid antibodies, higher composite anti-spike IgG levels were measured before the vaccine but no significant difference from unexposed individuals was observed at 6 months. Age, vaccine type, or worker role did not significantly impact composite IgG levels, although non-significant trends towards lower antibody levels in older participants and higher antibody levels with Moderna vaccine were observed at 6 months. A small subset of our cohort were classified as having waning antibody titers at 6 months, and these individuals were less likely to work in patient care roles and more likely to have prior exposure to SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Aged / Humans / Infant Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.817345

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Aged / Humans / Infant Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.817345